|
IT1199374B
(it)
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
|
IT1264494B1
(it)
*
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
|
US7048906B2
(en)
*
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US6861053B1
(en)
*
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
|
TW534813B
(en)
*
|
1997-02-28 |
2003-06-01 |
Kaneka Corp |
Treating agent for diseases due to infection with helicobacter
|
|
EP1453837A4
(en)
*
|
2001-11-21 |
2007-11-07 |
Activbiotics Inc |
TARGETED THERAPEUTIC AGENTS AND USES THEREOF
|
|
WO2003051299A2
(en)
*
|
2001-12-13 |
2003-06-26 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
|
US8758804B2
(en)
*
|
2002-11-05 |
2014-06-24 |
Fadim S.R.L. |
Controlled and continued delivery of rifaximin and/or other substances
|
|
US7820652B2
(en)
*
|
2003-09-24 |
2010-10-26 |
Activbiotics Pharma, Llc |
Regimen for the administration of rifamycin-class antibiotics
|
|
US7906542B2
(en)
*
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
|
US7923553B2
(en)
*
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
|
US7902206B2
(en)
*
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
|
US7265107B2
(en)
*
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
|
US7256187B2
(en)
*
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
|
US7202246B2
(en)
*
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
|
EP1698630B1
(en)
*
|
2005-03-03 |
2014-09-03 |
ALFA WASSERMANN S.p.A. |
New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
|
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
EA016059B1
(ru)
|
2005-08-11 |
2012-01-30 |
Тарганта Терапьютикс Инк. |
Фосфонированные рифамицины и их применение для профилактики и лечения костных и суставных инфекций
|
|
EP1996710B1
(en)
|
2006-03-09 |
2019-08-14 |
Salix Pharmaceuticals, Inc. |
Rifaximin anti-rectal dysfunction preparation
|
|
PT2054066E
(pt)
|
2006-08-02 |
2015-07-16 |
Salix Pharmaceuticals Inc |
Métodos para tratamento de enterite por radiação
|
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
|
CA2663776C
(en)
*
|
2006-09-22 |
2016-01-26 |
Cipla Limited |
Rifaximin in an amorphous form
|
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
|
JP5755878B2
(ja)
|
2007-07-06 |
2015-07-29 |
ルパン リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ |
リファキシミンの薬剤組成物
|
|
EP2420226B1
(en)
|
2007-07-06 |
2020-03-04 |
Lupin Limited |
Pharmaceutical compositions of rifaximin
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
|
WO2009108730A2
(en)
*
|
2008-02-25 |
2009-09-03 |
Salix Pharmaceuticals, Ltd. |
Forms of rifaximin and uses thereof
|
|
AU2009219240B2
(en)
|
2008-02-26 |
2014-10-16 |
Salix Pharmaceuticals, Ltd. |
Methods for treating bowel diseases
|
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
|
ES2509892T3
(es)
|
2008-05-07 |
2014-10-20 |
Salix Pharmaceuticals, Ltd. |
Administración de un agente para limpieza del intestino y antibiótico para el tratamiento de enfermedad intestinal
|
|
US8524691B2
(en)
|
2008-08-13 |
2013-09-03 |
The Medicines Company |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
CN102164599B
(zh)
|
2008-09-26 |
2014-07-23 |
Aska制药株式会社 |
预防和/或治疗功能性胃肠障碍的药剂
|
|
US12285414B2
(en)
|
2008-10-02 |
2025-04-29 |
Salix Pharmaceuticals, Inc. |
Methods of treating hepatic encephalopathy
|
|
SMT202400116T1
(it)
|
2008-10-02 |
2024-05-14 |
Salix Pharmaceuticals Ltd |
Trattamento dell’encefalopatia epatica utilizzando rifaximina
|
|
WO2010067072A1
(en)
|
2008-12-10 |
2010-06-17 |
Cipla Limited |
Rifaximin complexes
|
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
|
EP3964066A1
(en)
|
2009-06-02 |
2022-03-09 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
|
EP2475392A4
(en)
|
2009-09-13 |
2013-01-09 |
Salix Pharmaceuticals Ltd |
METHOD FOR TREATING IRRITATION SYNDROME
|
|
WO2011051971A2
(en)
|
2009-10-27 |
2011-05-05 |
Lupin Limited |
Solid dispersion of rifaximin
|
|
CA2781580A1
(en)
|
2009-11-23 |
2011-05-26 |
Cipla Limited |
Topical foam composition
|
|
EP2401282B2
(en)
|
2009-12-28 |
2017-01-04 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
|
JP5896380B2
(ja)
|
2010-02-18 |
2016-03-30 |
サリックス ファーマスーティカルズ，リミテッド |
感染症を治療するための方法
|
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
|
WO2011110930A2
(en)
|
2010-03-10 |
2011-09-15 |
Lupin Limited |
Rifaximin ready-to-use suspension
|
|
DK2593463T3
(da)
|
2010-07-12 |
2020-08-10 |
Salix Pharmaceuticals Inc |
Formuleringer af rifaximin og anvendelser deraf
|
|
WO2012035544A2
(en)
|
2010-09-13 |
2012-03-22 |
Sequent Scientific Ltd. |
A novel polymorphic form of rifaximin and process for its preparation
|
|
MX350448B
(es)
|
2011-02-11 |
2017-09-07 |
Salix Pharmaceuticals Ltd |
Formas de rifaximina y usos de las mismas.
|
|
AU2012251385A1
(en)
|
2011-05-02 |
2013-11-21 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
|
ITMI20110890A1
(it)
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
RU2496475C2
(ru)
|
2011-10-26 |
2013-10-27 |
Александр Васильевич Иващенко |
Фармацевтическая композиция и набор для лечения бактериальных инфекций
|
|
AU2012332211B2
(en)
|
2011-11-02 |
2016-11-24 |
Salix Pharmaceuticals, Ltd. |
Methods for treating irritable bowel syndrome (IBS) and infections
|
|
EP2807148A4
(en)
|
2012-01-25 |
2015-04-08 |
Salix Pharmaceuticals Ltd |
RIFAXIMIN DERIVATIVE AND USES THEREOF
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
US9849090B2
(en)
|
2012-12-12 |
2017-12-26 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions of rifaximin
|
|
MX2015011802A
(es)
|
2013-03-15 |
2016-01-08 |
Alfa Wassermann Spa |
Rifaximina para usarse en el tratamiento de infecciones vaginales.
|
|
WO2014140995A2
(en)
|
2013-03-15 |
2014-09-18 |
Alfa Wassermann S.P.A. |
Method for diagnosing vaginal infections
|
|
KR102190173B1
(ko)
|
2013-04-12 |
2020-12-14 |
알파시그마 에스.피.에이. |
Ｎｓａｉｄ 투여 및 관련 조성물, 방법 및 시스템
|
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
|
EP2927235B1
(en)
|
2014-03-31 |
2017-02-08 |
Euticals S.P.A. |
Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
|
|
EP3134415A4
(en)
*
|
2014-04-19 |
2017-10-25 |
Granules India Limited |
An improved process for the preparation of rifamycin derivatives
|
|
JP6693946B2
(ja)
|
2014-05-04 |
2020-05-13 |
サリックス ファーマスーティカルズ，インコーポレーテッド |
Ｉｂｓ微生物叢及びその使用
|
|
EA030457B1
(ru)
|
2014-05-12 |
2018-08-31 |
Альфасигма С.П.А. |
Новая сольватированная кристаллическая форма рифаксимина, ее получение, композиции и применения
|
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
|
CN110072525B
(zh)
|
2016-09-30 |
2022-12-02 |
萨利克斯药品公司 |
利福昔明的固态分散形式
|
|
IT201700091912A1
(it)
*
|
2017-08-08 |
2019-02-08 |
Biofer Spa |
Nuove pirido-imidazo rifamicine
|
|
CN110770244A
(zh)
*
|
2017-06-26 |
2020-02-07 |
倍尔福股份公司 |
吡啶并咪唑利福霉素衍生物的抗菌剂
|